Stoke Therapeutics's market cap is currently $462.93M. The company's EPS TTM is $-2.099; its P/E ratio is ―; Stoke Therapeutics is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 8.78M	$ 12.40M	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 8.78M	$ 8.87M	$ -2.23M	$ -1.93M	$ -450.00K
Operating Income	$ -114.77M	$ -104.36M	$ -86.06M	$ -53.04M	$ -35.68M
EBITDA	$ -112.30M	$ -102.81M	$ -83.58M	$ -50.32M	$ -35.23M
Net Income	$ -104.70M	$ -93.11M	$ -84.71M	$ -50.61M	$ -28.52M
Balance Sheet
Cash & Short-Term Investments	$ 201.39M	$ 229.59M	$ 219.81M	$ 287.31M	$ 222.47M
Total Assets	$ 228.34M	$ 256.07M	$ 238.87M	$ 297.93M	$ 228.75M
Total Debt	$ 2.06M	$ 2.36M	$ 1.51M	$ 80.00K	$ 0.00
Net Debt	$ -189.38M	$ -111.20M	$ -143.39M	$ -287.23M	$ -222.47M
Total Liabilities	$ 68.78M	$ 71.22M	$ 21.09M	$ 11.85M	$ 4.32M
Stockholders' Equity	$ 159.56M	$ 184.85M	$ 217.78M	$ 286.08M	$ 224.43M
Cash Flow
Free Cash Flow	$ -82.68M	$ -35.83M	$ -68.11M	$ -43.27M	$ -32.69M
Operating Cash Flow	$ -81.07M	$ -31.87M	$ -66.91M	$ -42.22M	$ -31.05M
Investing Cash Flow	$ 105.95M	$ -45.88M	$ -76.43M	$ -1.05M	$ -1.63M
Financing Cash Flow	$ 53.01M	$ 46.41M	$ 1.28M	$ 108.11M	$ 149.76M

Currency in USD

Stoke Therapeutics Earnings and Revenue History

Income Statement >

Stoke Therapeutics Debt to Assets

Balance Sheet >

Stoke Therapeutics Cash Flow

Cash Flow >

Stoke Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing